The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO

被引:0
|
作者
Xiaoqing Shi
Xiaofeng Huang
Rui Chen
Yan Li
Yinggang Xu
Weiwei Zhang
Qiannan Zhu
Xiaoming Zha
Jue Wang
机构
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Breast Disease
[2] Nanjing Medical University,Collaborative Innovation Center for Cancer Personalized Medicine
来源
Clinical & Experimental Metastasis | 2021年 / 38卷
关键词
Long noncoding RNAs (lncRNAs); Breast cancer; NONO; Ubiquitination; Tumor progression;
D O I
暂无
中图分类号
学科分类号
摘要
Long noncoding RNAs have recently emerged as significant contributors to cancers, including breast cancer (BC). One class of long noncoding RNAs called transcribed ultraconserved regions (T-UCRs) is highly conserved in many species and closely related to diverse physiological and pathological processes. However, the function of T-UCRs in BC remains largely unclear. In this study, we identified uc.51, a T-UCR that is overexpressed in both BC tissues and cell lines and is correlated with larger tumor size. Loss- and gain-of-function assays were performed in vitro and demonstrated that uc.51 promotes the proliferation, migration, and invasion of BC cells. Mechanistically, non-POU domain-containing octamer-binding protein (NONO) was found to physically interact with uc.51 by RNA pulldown followed by mass spectrometry. This interaction was further verified by RNA immunoprecipitation. Moreover, uc.51 positively regulated the expression of NONO, maintained its stability through the ubiquitin–proteasome system, and activated the phosphorylation of CREB. Rescue experiments demonstrated that NONO overexpression compensated for the attenuated influence on BC progression resulting from downregulation of uc.51, indicating that NONO functions downstream of uc.51. In vivo functional experiments also revealed a positive correlation between uc.51 expression and tumor size. Ki-67 and NONO levels in the lv-uc.51-shRNA group were decreased compared with those in the lv-con-shRNA group, according to the immunohistochemical staining results, and a decreased incidence of distant metastasis was observed in the lv-uc.51-shRNA group in the xenograft model. Collectively, our results reveal a substantial role for the uc.51-NONO axis in BC progression and indicate that the uc.51-NONO axis has potential to be a therapeutic target for BC.
引用
收藏
页码:551 / 571
页数:20
相关论文
共 50 条
  • [1] The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO
    Shi, Xiaoqing
    Huang, Xiaofeng
    Chen, Rui
    Li, Yan
    Xu, Yinggang
    Zhang, Weiwei
    Zhu, Qiannan
    Zha, Xiaoming
    Wang, Jue
    CLINICAL & EXPERIMENTAL METASTASIS, 2021, 38 (06) : 551 - 571
  • [2] TROAP Promotes Breast Cancer Proliferation and Metastasis
    Li, Kai
    Zhang, Ruo
    Wei, Minjie
    Zhao, Li
    Wang, Yu
    Feng, Xinxin
    Yang, Yongheng
    Yang, Shucai
    Zhang, Lei
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [3] Transcribed ultraconserved region Uc.63+promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer
    Sekino, Yohei
    Sakamoto, Naoya
    Ishikawa, Akira
    Honma, Ririno
    Shigematsu, Yoshinori
    Hayashi, Tetsutaro
    Sentani, Kazuhiro
    Oue, Naohide
    Teishima, Jun
    Matsubara, Akio
    Yasui, Wataru
    ONCOLOGY REPORTS, 2019, 41 (05) : 3111 - 3118
  • [4] Transcribed ultraconserved region Uc.63+promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer
    Sekino, Yohei
    Sakamoto, Naoya
    Goto, Keisuke
    Honma, Ririno
    Shigematsu, Yoshinori
    Sentani, Kazuhiro
    Oue, Naohide
    Teishima, Jun
    Matsubara, Akio
    Yasui, Wataru
    ONCOTARGET, 2017, 8 (55) : 94259 - 94270
  • [5] A transcribed ultraconserved noncoding RNA, uc.285+, promotes colorectal cancer proliferation through dual targeting of CDC42 by directly binding mRNA and protein
    Chen, Sixian
    Zhao, Qingyun
    Zhang, Ruirui
    Liu, Jungang
    Peng, Wenyi
    Xu, Haotian
    Li, Xiaofei
    Wang, Xin
    Wu, Shuilian
    Li, Gang
    Nan, Aruo
    TRANSLATIONAL RESEARCH, 2024, 270 : 52 - 65
  • [6] USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α
    Huang, Weixiao
    Liu, Xiong
    Zhang, Yao
    Deng, Mingxia
    Li, Guangqiang
    Chen, Guo
    Yu, Li
    Jin, Lai
    Liu, Tongzheng
    Wang, Yijie
    Chen, Yan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (04) : 2211 - 2219
  • [7] YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells
    Yang, Yi-Fang
    Lee, Yi-Chen
    Wang, Yen-Yun
    Wang, Chie-Hong
    Hou, Ming-Feng
    Yuan, Shyng-Shiou F.
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2019, 35 (07): : 408 - 416
  • [8] ARPC2 promotes breast cancer proliferation and metastasis
    Cheng, Zhongle
    Wei, Wei
    Wu, Zhengshen
    Wang, Jing
    Ding, Xiaojuan
    Sheng, Youjing
    Han, Yinli
    Wu, Qiang
    ONCOLOGY REPORTS, 2019, 41 (06) : 3189 - 3200
  • [9] DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC
    Wang, Yejinpeng
    Ju, Lingao
    Wang, Gang
    Qian, Kaiyu
    Jin, Wan
    Li, Mingxing
    Yu, Jingtian
    Shi, Yiliang
    Wang, Yongzhi
    Zhang, Yi
    Xiao, Yu
    Wang, Xinghuan
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [10] DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC
    Yejinpeng Wang
    Lingao Ju
    Gang Wang
    Kaiyu Qian
    Wan Jin
    Mingxing Li
    Jingtian Yu
    Yiliang Shi
    Yongzhi Wang
    Yi Zhang
    Yu Xiao
    Xinghuan Wang
    Nature Communications, 14